Valuation: Progyny, Inc.

Capitalization 127.68Cr 108.77Cr 100.66Cr 95Cr 176.54Cr 12TCr 180.16Cr 1.18TCr 462.05Cr 5.7TCr 479.14Cr 468.98Cr 20TCr P/E ratio 2026 *
13.9x
P/E ratio 2027 * 11.9x
Enterprise value 110.87Cr 94Cr 87Cr 82Cr 153.3Cr 10TCr 156.44Cr 1.03TCr 401.21Cr 4.95TCr 416.05Cr 407.23Cr 18TCr EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.61x
Free-Float
76.13%
Yield 2026 *
-
Yield 2027 * -
1 day-1.39%
1 week-1.81%
Current month-4.00%
1 month-6.86%
3 months-42.65%
6 months-18.91%
Current year-36.53%
1 week 16.1
Extreme 16.1
17.56
1 month 16.1
Extreme 16.1
18.6
Current year 16.1
Extreme 16.1
28.75
1 year 16.1
Extreme 16.1
28.75
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
Director of Finance/CFO 60 15/09/2020
Chief Operating Officer 56 17/04/2025
Director TitleAgeSince
Chairman 66 01/01/2022
Director/Board Member 77 16/12/2016
Director/Board Member 58 01/01/2022
Change 5d. change 1-year change 3-years change Capi.($)
-1.39%-1.81%-27.04%-49.47% 127.68Cr
-0.84%+9.76%-49.23%-41.61% 28TCr
-2.59%+0.46%-17.85%+4.02% 7.15TCr
-1.69%+3.59%-29.17%-36.81% 6.84TCr
-2.62%+8.05%-34.87%-63.88% 2.31TCr
-0.67%+6.24%-41.59%-44.48% 1.83TCr
+0.57%+4.66%-57.72%-50.72% 759.9Cr
-4.12%+9.28%+3.85%+198.40% 418.81Cr
+1.05%+12.21%-47.55%+139.37% 101.26Cr
+0.81%+10.87%-21.79% - 29Cr
Average -0.84%+6.10%-32.30%+6.09% 4.72TCr
Weighted average by Cap. -0.90%+7.12%-40.15%-32.84%

Financials

2026 *2027 *
Net sales 137.51Cr 117.14Cr 108.41Cr 102.08Cr 190.14Cr 13TCr 194.03Cr 1.27TCr 497.63Cr 6.14TCr 516.03Cr 505.1Cr 22TCr 150.8Cr 128.47Cr 118.89Cr 111.94Cr 208.51Cr 14TCr 212.78Cr 1.39TCr 545.73Cr 6.73TCr 565.91Cr 553.91Cr 24TCr
Net income 10Cr 8.69Cr 8.04Cr 7.57Cr 14Cr 948.44Cr 14Cr 94Cr 37Cr 455.45Cr 38Cr 37Cr 1.62TCr 12Cr 10Cr 9.42Cr 8.87Cr 17Cr 1.11TCr 17Cr 110.55Cr 43Cr 533.83Cr 45Cr 44Cr 1.9TCr
Net Debt -17Cr -14Cr -13Cr -12Cr -23Cr -1.56TCr -24Cr -155.49Cr -61Cr -750.82Cr -63Cr -62Cr -2.68TCr -36Cr -31Cr -28Cr -27Cr -50Cr -3.34TCr -51Cr -332.03Cr -129.92Cr -1.6TCr -134.72Cr -131.87Cr -5.71TCr
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
10/26/10 16.30 $ -1.39% 9,46,290
09/26/09 16.53 $ -2.36% 11,92,156
08/26/08 16.93 $ -1.34% 14,42,504
07/26/07 17.16 $ +2.26% 14,67,029
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.30USD
Average target price
27.45USD
Spread / Average Target
+68.43%

Quarterly revenue - Rate of surprise